Lam, Barbara D.
Dodge, Laura E.
Zerbey, Sabrina
Robertson, William
Rosovsky, Rachel P.
Lake, Leslie
Datta, Siddhant
Elavakanar, Pavania
Adamski, Alys
Reyes, Nimia
Abe, Karon
Vlachos, Ioannis S.
Zwicker, Jeffrey I.
Patell, Rushad
Funding for this research was provided by:
Centers for Disease Control and Prevention Foundation (DD20-2002)
Article History
Received: 8 June 2023
Accepted: 17 May 2024
First Online: 26 May 2024
Competing interests
: Funding source: This study was supported by the Centers for Disease Control and Prevention (CDC), Atlanta, GA USA Cooperative Agreement #DD20-2002. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. Rachel P. Rosovsky, MD, MPH has received research funding from Bristol Myers Squibb and Janssen; consultancy/advisory board participation with Abbott, Bristol Myers Squibb, Janssen, Inari, and Penumbra. Jeffrey I. Zwicker, MD has received research funding from Incyte, Quercegen, and the National Heart, Lung, and Blood Institute; provided consultancy services to Sanofi, CSL, and Parexel; and received honoraria from/advisory board participation with Pfizer/Bristol Myers Squibb, Portola, Daiichi. All other authors report no conflicts of interest.